Osiris Therapeutics (OSIR) Posts Q4 Loss of 8c/Share
Tweet Send to a Friend
Osiris Therapeutics (NASDAQ: OSIR) reported Q4 EPS of ($0.08), $0.07 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
